815 related articles for article (PubMed ID: 17353778)
21. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
22. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
25. Spanish experience with cyclosporine.
Pascual J; Marcén R; Burgos FJ; Villafruela JJ; Teruel JL; Mampaso F; Quereda C; Ortuño J
Transplant Proc; 2004 Mar; 36(2 Suppl):117S-119S. PubMed ID: 15041319
[TBL] [Abstract][Full Text] [Related]
26. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[TBL] [Abstract][Full Text] [Related]
27. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
28. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
29. Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
Salvadori M; Scolari MP; Bertoni E; Citterio F; Rigotti P; Cossu M; Dal Canton A; Tisone G; Albertazzi A; Pisani F; Gubbiotti G; Piredda G; Busnach G; Sparacino V; Goepel V; Messa P; Berloco P; Montanaro D; Veroux P; Federico S; Bartezaghi M; Corbetta G; Ponticelli C
Transplantation; 2009 Nov; 88(10):1194-202. PubMed ID: 19935373
[TBL] [Abstract][Full Text] [Related]
30. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
31. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine.
Hilbrands LB; Hoitsma AG; Wetzels JF; Koene RA
Clin Nephrol; 1996 Apr; 45(4):230-5. PubMed ID: 8861797
[TBL] [Abstract][Full Text] [Related]
32. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
[TBL] [Abstract][Full Text] [Related]
34. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
Salvadori M; Rosati A; Bertoni E; Bock A; Chapman J; Dussol B; Fritsche L; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G; Soergel M
Transplant Proc; 2006 May; 38(4):1010-3. PubMed ID: 16757247
[TBL] [Abstract][Full Text] [Related]
35. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
[TBL] [Abstract][Full Text] [Related]
36. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
37. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
Chang HR; Lin CC; Lian JD
Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
40. The effect of immunosuppressive drugs on quality of life after renal transplantation.
Hilbrands LB; Hoitsma AJ; Koene RA
Transplantation; 1995 May; 59(9):1263-70. PubMed ID: 7762059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
